Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug approved in decades and the first in a new class of medications. British ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

During that process, the DNA can become knotted ... chief scientific officer at GSK (which makes Blujepa), said during a press briefing that this process is unique to E. coli bacteria, and ...

GSK has revealed updated results from its phase ... resulted in sustained hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the limits of detection in 9% to 10% of participants with ...

An antisense drug in development at GSK has shown further activity against ... levels of hepatitis B surface antigen (HBsAg) and HBV DNA after 24 weeks' treatment to below the lower limit of ...